# Collegium Pharmaceutical, Inc: Form 8-K, filed Feb 13, 2020

- Company: [Collegium Pharmaceutical, Inc](/companies/coll.md) (CIK 1267565)
- Form: 8-K
- Filed: 2020-02-13
- Accepted by EDGAR: Feb 13, 2020, 17:10 ET
- Period: 2020-02-10
- Accession: 0001104659-20-020297
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1267565/000110465920020297/tm207070d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1267565/000110465920020297/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 2.03: New direct financial obligation
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1267565/000110465920020297/tm207070d2_8k.htm

Filed Feb 13, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-020297. Last ingested by Listed: Nov 10, 2026, 23:07 ET. No prices; not investment advice.
